>
CASE STUDY 1
Advancement of an Early Development Candidate to Phase IIb Trials
>
CASE STUDY 2
Development of a Parenteral Formulation of a Cytotoxic Natural Product
>
CASE STUDY 3
Oral Formulation Development for Proof-of-Concept Animal Toxicology Studies
>
CASE STUDY 4
cGMP Analytical Release Testing of a Cytotoxic Drug, as Well as Other Analytical and Bioanalytical Services
>
CASE STUDY 5
Parenteral Dosage Form Development of a Highly Insoluble Molecule
Request Information
To download our comprehensive brochure of IND-enabling services,
click here
.
Name:
Email:
Telephone:
Comments:
© 2009 Wolfe Laboratories, Inc. All rights reserved.
